taxonomy (1)
protein (1)
source (1)
structure (0)
composition (28)
disease (1)
reference (2)
site (14)
peptide (14)
- Homo sapiens (Human)
Taxonomy
- Blood Serum (UBERON_0001977)
Source
Reported structure
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:2 NeuAc:1
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2590.3886 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:3
- Hex:6 HexNAc:5 dHex:3 NeuAc:1
- Hex:6 HexNAc:5 dHex:3 NeuAc:3
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:6 HexNAc:6 NeuAc:3 (avg mass : 3083.8134 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3229.9564 )
- Hex:6 HexNAc:6 dHex:2 NeuAc:2
- Hex:6 HexNAc:6 dHex:3 NeuAc:2
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2809.583 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:2 NeuAc:2
- Hex:7 HexNAc:6 dHex:2 NeuAc:3
- Hex:7 HexNAc:6 dHex:2 NeuAc:4 (avg mass : 3829.4997 )
- Hex:7 HexNAc:6 dHex:3 NeuAc:2
Composition
- Prostate cancer (DOID:10283)
Disease
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
Reference
- Adhesion G protein-coupled receptor F5 / Homo sapiens
Reported glycosite
- LNVGFQEDLMNTSSALYR (18aa)
- ANEQVVQSLNQTYK (14aa)
- EVLSSNVSWR (10aa)
- YEEQQLEIQNSSR (13aa)
- FSIYTALFNNMTSVSK (16aa)
- LTIHNITPGDAGEYVCK (17aa)
- VMCDNNPVSLNCCSQGNVNWSK (22aa)
- CISDVSNYDEVYWNTSAGIK (20aa)
- EWNGTYHCIFR (11aa)
- HNFNASSVSWCSK (13aa)
- TVDVCCHFTNAANNSVWSPSMK (22aa)
- NDCISAPINSLLQMAK (16aa)
- VLQQQWTNQSSQLLHSVER (19aa)
- NVCWLNWEDTK (11aa)
Mass spectrometry observed peptide
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- NDCISAPINSLLQMAK (16aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
- LTIHNITPGDAGEYVCK (17aa)
- VMCDNNPVSLNCCSQGNVNWSK (22aa)
- TVDVCCHFTNAANNSVWSPSMK (22aa)
- NDCISAPINSLLQMAK (16aa)
- VLQQQWTNQSSQLLHSVER (19aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- ANEQVVQSLNQTYK (14aa)
- NDCISAPINSLLQMAK (16aa)
- NVCWLNWEDTK (11aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- NDCISAPINSLLQMAK (16aa)
-
- Hex:6 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
- CISDVSNYDEVYWNTSAGIK (20aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- ANEQVVQSLNQTYK (14aa)
- EVLSSNVSWR (10aa)
- EWNGTYHCIFR (11aa)
- HNFNASSVSWCSK (13aa)
- NDCISAPINSLLQMAK (16aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2516.3091)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- ANEQVVQSLNQTYK (14aa)
- EVLSSNVSWR (10aa)
- YEEQQLEIQNSSR (13aa)
- NDCISAPINSLLQMAK (16aa)
- NVCWLNWEDTK (11aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 / N-Linked (avg mass : 2590.3886)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
- YEEQQLEIQNSSR (13aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- FSIYTALFNNMTSVSK (16aa)
- NDCISAPINSLLQMAK (16aa)
-
- Hex:6 HexNAc:6 NeuAc:2 / N-Linked (avg mass : 2792.5555)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- LNVGFQEDLMNTSSALYR (18aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 / N-Linked (avg mass : 2881.6465)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- ANEQVVQSLNQTYK (14aa)
- EVLSSNVSWR (10aa)
- YEEQQLEIQNSSR (13aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 2938.6985)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- LNVGFQEDLMNTSSALYR (18aa)
- ANEQVVQSLNQTYK (14aa)
- EVLSSNVSWR (10aa)
- YEEQQLEIQNSSR (13aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:3 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
- NDCISAPINSLLQMAK (16aa)
-
- Hex:6 HexNAc:6 NeuAc:3 / N-Linked (avg mass : 3083.8134)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- LNVGFQEDLMNTSSALYR (18aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3229.9564)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EVLSSNVSWR (10aa)
-
- Hex:6 HexNAc:6 dHex:2 NeuAc:2 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- ANEQVVQSLNQTYK (14aa)
- HNFNASSVSWCSK (13aa)
-
- Hex:6 HexNAc:6 dHex:3 NeuAc:2 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- HNFNASSVSWCSK (13aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 / N-Linked (avg mass : 2809.583)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- NDCISAPINSLLQMAK (16aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3392.0988)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- NDCISAPINSLLQMAK (16aa)
-
- Hex:7 HexNAc:6 dHex:2 NeuAc:2 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- YEEQQLEIQNSSR (13aa)
- NDCISAPINSLLQMAK (16aa)
-
- Hex:7 HexNAc:6 dHex:2 NeuAc:3 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- YEEQQLEIQNSSR (13aa)
-
- Hex:7 HexNAc:6 dHex:2 NeuAc:4 / N-Linked (avg mass : 3829.4997)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- YEEQQLEIQNSSR (13aa)
-
- Hex:7 HexNAc:6 dHex:3 NeuAc:2 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- EWNGTYHCIFR (11aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
